claim: chop researchers find elevated biomarker related to blood vessel damage in all children with sars-cov-2 regardless of disease severity.
evidence_1: to assess the role of complement activation in children with sars-cov-2, the immune dysregulation frontier program, including co-senior authors edward behrens, md and hamid bassiri, md, phd and co-first authors caroline diorio, md and kevin mcnerney, md, analyzed 50 pediatric patients hospitalized at chop with acute sars-cov-2 infection between april and july 2020.